# Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

> **NCT01654718** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pantoprazole
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT01654718
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-11
- **Final completion:** 2009-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654718, "Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01654718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*